These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35714514)

  • 21. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
    Okuno A; Fukuwatari T; Shibata K
    J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
    Ceresoli-Borroni G; Rassoulpour A; Wu HQ; Guidetti P; Schwarcz R
    J Neural Transm (Vienna); 2006 Oct; 113(10):1355-65. PubMed ID: 16465454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.
    Füvesi J; Somlai C; Németh H; Varga H; Kis Z; Farkas T; Károly N; Dobszay M; Penke Z; Penke B; Vécsei L; Toldi J
    Pharmacol Biochem Behav; 2004 Jan; 77(1):95-102. PubMed ID: 14724046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB
    Zádor F; Nagy-Grócz G; Dvorácskó S; Bohár Z; Cseh EK; Zádori D; Párdutz Á; Szűcs E; Tömböly C; Borsodi A; Benyhe S; Vécsei L
    Neurochem Int; 2020 Sep; 138():104752. PubMed ID: 32445659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a kynurenic acid analog on home-cage activity and body temperature in rats.
    Kassai F; Kedves R; Gyertyán I; Tuka B; Fülöp F; Toldi J; Lendvai B; Vécsei L
    Pharmacol Rep; 2015 Dec; 67(6):1188-92. PubMed ID: 26481540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological effects of some kynurenic acid analogs.
    Nagy K; Plangár I; Tuka B; Gellért L; Varga D; Demeter I; Farkas T; Kis Z; Marosi M; Zádori D; Klivényi P; Fülöp F; Szatmári I; Vécsei L; Toldi J
    Bioorg Med Chem; 2011 Dec; 19(24):7590-6. PubMed ID: 22079867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction.
    Klein C; Patte-Mensah C; Taleb O; Bourguignon JJ; Schmitt M; Bihel F; Maitre M; Mensah-Nyagan AG
    Neuropharmacology; 2013 Jul; 70():254-60. PubMed ID: 23422298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
    Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
    Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1-3 and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 in Whole Blood Cultures of Patients With Rheumatoid Arthritis.
    Balog A; Varga B; Fülöp F; Lantos I; Toldi G; Vécsei L; Mándi Y
    Front Immunol; 2021; 12():632513. PubMed ID: 33897688
    [No Abstract]   [Full Text] [Related]  

  • 30. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies.
    Németh H; Toldi J; Vécsei L
    J Neural Transm Suppl; 2006; (70):285-304. PubMed ID: 17017544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
    Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
    J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
    Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
    Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kynurenic acid protects against mastitis in mice by ameliorating inflammatory responses and enhancing blood-milk barrier integrity.
    Zhao C; Wu K; Bao L; Chen L; Feng L; Liu Z; Wang Y; Fu Y; Zhang N; Hu X
    Mol Immunol; 2021 Sep; 137():134-144. PubMed ID: 34247099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kynurenic Acid Restores Nrf2 Levels and Prevents Quinolinic Acid-Induced Toxicity in Rat Striatal Slices.
    Ferreira FS; Biasibetti-Brendler H; Pierozan P; Schmitz F; Bertó CG; Prezzi CA; Manfredini V; Wyse ATS
    Mol Neurobiol; 2018 Nov; 55(11):8538-8549. PubMed ID: 29564809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid.
    Goeden N; Notarangelo FM; Pocivavsek A; Beggiato S; Bonnin A; Schwarcz R
    Dev Neurosci; 2017; 39(6):519-528. PubMed ID: 29080891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic kainic acid administration in rats: effects on kynurenic acid production in vitro and in vivo.
    Wu HQ; Turski WA; Ungerstedt U; Schwarcz R
    Exp Neurol; 1991 Jul; 113(1):47-52. PubMed ID: 2044678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer's disease.
    Sharma R; Razdan K; Bansal Y; Kuhad A
    Expert Opin Ther Targets; 2018 Oct; 22(10):849-867. PubMed ID: 30223691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective Activation by Kynurenic Acid and Its Aminoalkylated Derivatives on M-Type K
    Lo YC; Lin CL; Fang WY; Lőrinczi B; Szatmári I; Chang WH; Fülöp F; Wu SN
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
    Meier TB; Drevets WC; Teague TK; Wurfel BE; Mueller SC; Bodurka J; Dantzer R; Savitz J
    Brain Behav Immun; 2018 Jan; 67():59-64. PubMed ID: 28867283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.